These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 19412666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.
    van der Sloot AM, Tur V, Szegezdi E, Mullally MM, Cool RH, Samali A, Serrano L, Quax WJ.
    Proc Natl Acad Sci U S A; 2006 Jun 06; 103(23):8634-9. PubMed ID: 16731632
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 4. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y, Zhang B.
    Mol Cancer Res; 2008 Dec 15; 6(12):1861-71. PubMed ID: 19074831
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors.
    Reis CR, van der Sloot AM, Szegezdi E, Natoni A, Tur V, Cool RH, Samali A, Serrano L, Quax WJ.
    Biochemistry; 2009 Mar 17; 48(10):2180-91. PubMed ID: 19236007
    [Abstract] [Full Text] [Related]

  • 6. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 7. Synthetic constrained peptide selectively binds and antagonizes death receptor 5.
    Vrielink J, Heins MS, Setroikromo R, Szegezdi E, Mullally MM, Samali A, Quax WJ.
    FEBS J; 2010 Apr 28; 277(7):1653-65. PubMed ID: 20156289
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D.
    FEBS J; 2008 Apr 28; 275(8):1925-36. PubMed ID: 18341587
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
    Cappellini A, Mantovani I, Tazzari PL, Grafone T, Martinelli G, Cocco L, Martelli AM.
    Int J Mol Med; 2005 Dec 28; 16(6):1041-8. PubMed ID: 16273284
    [Abstract] [Full Text] [Related]

  • 11. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY.
    Mol Pharmacol; 2007 Nov 28; 72(5):1269-79. PubMed ID: 17684158
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
    Mori T, Doi R, Toyoda E, Koizumi M, Ito D, Kami K, Kida A, Masui T, Kawaguchi Y, Fujimoto K.
    Surgery; 2005 Jul 28; 138(1):71-7. PubMed ID: 16003319
    [Abstract] [Full Text] [Related]

  • 13. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 28; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 14. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 15. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
    Vindrieux D, Réveiller M, Florin A, Blanchard C, Ruffion A, Devonec M, Benahmed M, Grataroli R.
    J Cell Physiol; 2006 Mar 01; 206(3):709-17. PubMed ID: 16245307
    [Abstract] [Full Text] [Related]

  • 16. TRAIL upregulates decoy receptor 1 and mediates resistance to apoptosis in insulin-secreting INS-1 cells.
    Kang S, Park SY, Lee HJ, Yoo YH.
    Biochem Biophys Res Commun; 2010 Jun 04; 396(3):731-5. PubMed ID: 20451496
    [Abstract] [Full Text] [Related]

  • 17. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T.
    Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136
    [Abstract] [Full Text] [Related]

  • 18. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A.
    J Cell Physiol; 2009 Nov 01; 221(2):378-86. PubMed ID: 19562684
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism.
    Pei GT, Wu CW, Lin WW.
    Biochem Biophys Res Commun; 2010 Jan 08; 391(2):1274-9. PubMed ID: 20018172
    [Abstract] [Full Text] [Related]

  • 20. Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
    Ohtsuki T, Kikuchi H, Koyano T, Kowithayakorn T, Sakai T, Ishibashi M.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6748-54. PubMed ID: 19682913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.